BIOMAT Database Logo BIOMAT Database Logo

Substituted piperazines as novel dipeptidyl peptidase IV inhibitors. 2004

Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Department of Medicinal Chemistry, Merck & Co. Inc., PO Box 2000, Rahway, NJ 07065, USA. linda_brockunier@merck.com

Incorporation of a fluorophenyl beta-amino amide moiety into piperazine screening lead 2 has resulted in the discovery of a structurally novel series of potent and selective DP-IV inhibitors. Simplification of the molecule and incorporation of multiple fluorine atoms on the phenyl ring has provided low molecular weight analogs such as compound 32, which is a 19nM DP-IV inhibitor with >4000-fold selectivity over QPP.

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease.
September 2017, Vascular pharmacology,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
June 2006, Bioorganic & medicinal chemistry letters,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors.
February 2010, Bioorganic & medicinal chemistry letters,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Dipeptidyl peptidase IV inhibitors.
June 2002, IDrugs : the investigational drugs journal,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors.
March 2004, Bioorganic & medicinal chemistry letters,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors.
December 2006, Bioorganic & medicinal chemistry letters,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors.
August 2009, Bioorganic & medicinal chemistry letters,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors.
September 2005, Bioorganic & medicinal chemistry letters,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Dipeptide phosphonates as inhibitors of dipeptidyl peptidase IV.
November 1994, Journal of medicinal chemistry,
Linda L Brockunier, and Jiafang He, and Lawrence F Colwell, and Bahanu Habulihaz, and Huaibing He, and Barbara Leiting, and Kathryn A Lyons, and Frank Marsilio, and Reshma A Patel, and Yohannes Teffera, and Joseph K Wu, and Nancy A Thornberry, and Ann E Weber, and Emma R Parmee
Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor.
September 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!